Study of Serum-Ferritin Level in Stroke Patients and its Outcome in Patients Admitted in Tertiary Care Centre

Background: Stroke is a leading cause of morbidity and mortality worldwide, with inflammation playing a pivotal role in its pathogenesis. Serum ferritin, an acute-phase reactant and marker of iron metabolism, is linked to oxidative stress and inflammation, potentially influencing stroke outcomes. Studying its levels may provide insights into prognosis and therapeutic targets in stroke management. Aim and Objectives: To assess the level of serum ferritin in stroke patients admitted in tertiary care centre and to correlate the level of serum ferritin with the disease outcome in the patients. Materials and Methods: This study was conducted as a prospective Observational Study on Patients admitted in medicine ICU, tertiary care hospital, Bhopal, during the study period of 18 months i.e. from 1st September 2022 to 29th February 2024. The clinical severity of stroke was assessed using Canadian Stroke Scale at the time of admission and on the 6th day of admission, the severity of stroke was re-assessed clinically using CSS and serum ferritin levels were again measured in all the subjects. Results: Mean serum ferritin levels in patients with admitted with stroke at the time of admission was 276.30±155.52 ng/ml whereas that at day 6 was 301.95±228.86 ng/ml. 51 cases (31.9%) with stroke deteriorated over the hospital stay. Mean serum ferritin levels in deteriorated group was significantly higher as compared to non-deteriorated group (p<0.05). Serum ferritin at day 6 to be good predictor of adverse outcome i.e. deterioration as per CSS (AUC=0.897; 95% CI-0.842-0.951; p<0.05) and serum ferritin at admission was found to be fair predictor of adverse outcome (AUC=0.798; 95% CI- 0.723-0.873; p<0.05). Conclusions: Serum ferritin levels are prognostic marker of severity of stroke as well as outcome in patients with stroke. Elevated serum ferritin is strongly positively correlated with early neurological deterioration in stroke patients. Elevated serum ferritin, a marker of iron stores, thus not only help in predicting short term and long term prognosis but signals the need for more intensive patient care and management protocols.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-28
DOI
https://doi.org/10.5281/zenodo.14589198
Primary Topic
Parasite Biology and Host Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of Serum-Ferritin Level in Stroke Patients and its Outcome in Patients Admitted in Tertiary Care Centre

Zenodo (CERN European Organization for Nuclear Research)
Parasite Biology and Host Interactions
article

Study of Serum-Ferritin Level in Stroke Patients and its Outcome in Patients Admitted in Tertiary Care Centre

article en

Abstract

Background: Stroke is a leading cause of morbidity and mortality worldwide, with inflammation playing a pivotal role in its pathogenesis. Serum ferritin, an acute-phase reactant and marker of iron metabolism, is linked to oxidative stress and inflammation, potentially influencing stroke outcomes. Studying its levels may provide insights into prognosis and therapeutic targets in stroke management. Aim and Objectives: To assess the level of serum ferritin in stroke patients admitted in tertiary care centre and to correlate the level of serum ferritin with the disease outcome in the patients. Materials and Methods: This study was conducted as a prospective Observational Study on Patients admitted in medicine ICU, tertiary care hospital, Bhopal, during the study period of 18 months i.e. from 1st September 2022 to 29th February 2024. The clinical severity of stroke was assessed using Canadian Stroke Scale at the time of admission and on the 6th day of admission, the severity of stroke was re-assessed clinically using CSS and serum ferritin levels were again measured in all the subjects. Results: Mean serum ferritin levels in patients with admitted with stroke at the time of admission was 276.30±155.52 ng/ml whereas that at day 6 was 301.95±228.86 ng/ml. 51 cases (31.9%) with stroke deteriorated over the hospital stay. Mean serum ferritin levels in deteriorated group was significantly higher as compared to non-deteriorated group (p<0.05). Serum ferritin at day 6 to be good predictor of adverse outcome i.e. deterioration as per CSS (AUC=0.897; 95% CI-0.842-0.951; p<0.05) and serum ferritin at admission was found to be fair predictor of adverse outcome (AUC=0.798; 95% CI- 0.723-0.873; p<0.05). Conclusions: Serum ferritin levels are prognostic marker of severity of stroke as well as outcome in patients with stroke. Elevated serum ferritin is strongly positively correlated with early neurological deterioration in stroke patients. Elevated serum ferritin, a marker of iron stores, thus not only help in predicting short term and long term prognosis but signals the need for more intensive patient care and management protocols.

Zenodo (CERN European Organization for Nuclear Research)
Hamidia Hospital (IN)
Good health and well-being
Openalex Percentile: Top 60%
Parasite Biology and Host Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Study of Serum-Ferritin Level in Stroke Patients and its Outcome in Patients Admitted in Tertiary Care Centre · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS